According to Bausch Health
's latest financial reports the company has $0.94 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.94 B | 67.91% |
2022-12-31 | $0.56 B | -3.09% |
2021-12-31 | $0.58 B | -3.8% |
2020-12-31 | $0.60 B | -81.34% |
2019-12-31 | $3.24 B | 349.79% |
2018-12-31 | $0.72 B | 0.14% |
2017-12-31 | $0.72 B | 32.84% |
2016-12-31 | $0.54 B | -9.21% |
2015-12-31 | $0.59 B | 85.06% |
2014-12-31 | $0.32 B | -46.26% |
2013-12-31 | $0.60 B | -34.47% |
2012-12-31 | $0.91 B | 437.46% |
2011-12-31 | $0.17 B | -57.43% |
2010-12-31 | $0.40 B | 222.79% |
2009-12-31 | $0.12 B | -61.03% |
2008-12-31 | $0.31 B | -27.26% |
2007-12-31 | $0.43 B | -47.57% |
2006-12-31 | $0.83 B | 87.21% |
2005-12-31 | $0.44 B | 1033.16% |
2004-12-31 | $39.34 M | -70.48% |
2003-12-31 | $0.13 B | 137.63% |
2002-12-31 | $56.08 M | -87.1% |
2001-12-31 | $0.43 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -89.88% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -97.33% | ๐บ๐ธ USA |